Evaluation of oral telmisartan administration as a suppression test for diagnosis of primary hyperaldosteronism in cats

BACKGROUND: Development of a telmisartan‐based suppression test may facilitate the diagnosis of primary hyperaldosteronism (PHA) in cats, which remains difficult today. OBJECTIVES: To develop a telmisartan suppression test (TST) that is safe, and able to suppress aldosterone secretion in healthy cat...

Descripción completa

Detalles Bibliográficos
Autores principales: Fabrès, Virginie, Dumont, Renaud, Garcia, Mélanie, Rosenberg, Dan, Rannou, Benoit, Kurtz, Maxine, Benchekroun, Ghita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365039/
https://www.ncbi.nlm.nih.gov/pubmed/36988582
http://dx.doi.org/10.1111/jvim.16689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365039/
https://www.ncbi.nlm.nih.gov/pubmed/36988582
http://dx.doi.org/10.1111/jvim.16689

Ejemplares similares